13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001583977-25-000007
Total Value
$1.34B
Positions
42
Other Managers
1
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,494,151 | $400.9M | 29.86% |
| 2 | EYEPOINT PHARMACEUTICALS INC | EYPT | 8,325,000 | $78.3M | 5.84% |
| 3 | BRIDGEBIO PHARMA INC | BBIO | 1,600,000 | $69.1M | 5.15% |
| 4 | PRAXIS PRECISION MEDICINES I | PRAX | 1,625,000 | $68.3M | 5.09% |
| 5 | MERUS N V | N5749R100 | 1,120,000 | $58.9M | 4.39% |
| 6 | EDGEWISE THERAPEUTICS INC | EWTX | 4,251,992 | $55.7M | 4.15% |
| 7 | INSMED INC | INSM | 540,000 | $54.3M | 4.05% |
| 8 | ARCELLX INC | ACLX | 800,000 | $52.7M | 3.92% |
| 9 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,175,000 | $39.4M | 2.93% |
| 10 | JANUX THERAPEUTICS INC | JANX | 1,500,000 | $34.6M | 2.58% |
| 11 | RAPPORT THERAPEUTICS INC | RAPP | 2,940,921 | $33.4M | 2.49% |
| 12 | VERONA PHARMA PLC | 925050106 | 350,000 | $33.1M | 2.47% |
| 13 | HELIX ACQUISITION CORP II | HLXC | 2,909,000 | $30.9M | 2.30% |
| 14 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 1,059,331 | $27.7M | 2.06% |
| 15 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,086,600 | $27.4M | 2.04% |
| 16 | PHARVARIS N V | PHVS | 1,454,660 | $25.6M | 1.91% |
| 17 | GH RESEARCH PLC | GHRS | 2,009,482 | $24.5M | 1.82% |
| 18 | ARS PHARMACEUTICALS INC | SPRY | 1,100,000 | $19.2M | 1.43% |
| 19 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 2,375,000 | $16.4M | 1.22% |
| 20 | ABIVAX SA | AAVXF | 2,130,000 | $16.3M | 1.21% |
| 21 | CG ONCOLOGY INC | CGON | 625,000 | $16.3M | 1.21% |
| 22 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,000,000 | $14.0M | 1.04% |
| 23 | CARGO THERAPEUTICS INC | 14179K101 | 3,381,277 | $13.9M | 1.04% |
| 24 | TARSUS PHARMACEUTICALS INC | TARS | 300,000 | $12.2M | 0.91% |
| 25 | CRINETICS PHARMACEUTICALS IN | CRNX | 400,000 | $11.5M | 0.86% |
| 26 | METSERA INC | 59267L107 | 400,000 | $11.4M | 0.85% |
| 27 | AARDVARK THERAPEUTICS INC | AARD | 800,189 | $10.8M | 0.81% |
| 28 | AXSOME THERAPEUTICS INC | AXSM | 100,000 | $10.4M | 0.78% |
| 29 | BIOAGE LABS INC | BIOA | 2,140,605 | $8.8M | 0.66% |
| 30 | ENGENE HOLDINGS INC | ENGNW | 2,323,595 | $8.5M | 0.63% |
| 31 | MBX BIOSCIENCES INC | MBX | 700,000 | $8.0M | 0.59% |
| 32 | CABALETTA BIO INC | CABA | 5,000,000 | $7.6M | 0.57% |
| 33 | ALUMIS INC | ALMS | 2,147,396 | $6.4M | 0.48% |
| 34 | BIOMEA FUSION INC | BMEA | 3,570,872 | $6.4M | 0.48% |
| 35 | KORRO BIO INC | KRRO | 465,000 | $5.8M | 0.43% |
| 36 | VAXCYTE INC | PCVX | 175,000 | $5.7M | 0.42% |
| 37 | AVIDITY BIOSCIENCES INC | 05370A108 | 200,000 | $5.7M | 0.42% |
| 38 | ENLIVEN THERAPEUTICS INC | ELVN | 200,000 | $4.0M | 0.30% |
| 39 | STOKE THERAPEUTICS INC | STOK | 254,161 | $2.9M | 0.21% |
| 40 | KALA BIO INC | KALA | 603,027 | $2.9M | 0.21% |
| 41 | VYNE THERAPEUTICS INC | VYNE | 1,370,938 | $2.3M | 0.17% |
| 42 | BIOHAVEN LTD | BHVN | 10,000 | $141,100 | 0.01% |